The genetics of RSD: is there a hereditary component?

RSD is the older name for complex regional pain syndrome (CRPS), a regional pain condition involving altered pain processing, autonomic nervous system function and sometimes movement, skin and sweating changes. Research into the genetics of RSD forms one part of the puzzle, but genetic susceptibility is neither a diagnosis nor a prediction.

People with CRPS and their relatives often ask whether the condition can pass from one generation to the next. The available evidence suggests that inherited susceptibility may contribute, while environmental and biological factors influence how strongly it is expressed.

Understanding RSD and CRPS

Common symptoms include burning or aching pain, extreme sensitivity to touch, swelling, stiffness, changes in skin colour or temperature, unusual sweating and sometimes difficulty moving the affected limb. Pain may spread beyond the original injury, fluctuate over time and affect sleep, work and daily activities.

The label RSD is usually used for CRPS I. In CRPS II, a confirmed nerve injury is present, and the condition is also called causalgia. This distinction matters because genetic findings in one group cannot automatically be applied to the other. The pain is real even when examinations or scans appear reassuring.

Evidence for inherited susceptibility

Most cases are sporadic, and the evidence points to susceptibility rather than a simple inherited disorder. Small family clusters and studies of immune, sensory and autonomic pathways suggest a genetic contribution. Certain human leukocyte antigen (HLA) types have been associated with CRPS in some cohorts, yet results have not been consistent across populations or large studies.

Twin observations are especially informative because identical twins usually share much more DNA than unrelated people. Reports of twins in whom only one developed CRPS after similar triggers show that genes are not sufficient on their own. A family history may raise clinical suspicion, but it cannot predict whether a relative will develop the condition or how severe it will be.

Possible causes and biological triggers

CRPS often follows a fracture, soft-tissue injury, surgery or prolonged immobilisation, although some cases have no obvious trigger. The body may become sensitised, with nervous system signals amplifying pain and changes in blood flow, inflammation or movement. These mechanisms are active biological processes, not evidence that symptoms are imagined.

Gene regulation may also contribute. Environmental events and sustained stress can alter the activity of genes involved in inflammation and pain pathways without changing their DNA sequence. This epigenetic regulation may help explain why the same injury can produce very different outcomes in different people, but it is distinct from an inherited DNA variant.

Diagnosis and the role of genetic testing

Diagnosis is clinical. A clinician looks for the pattern of pain, sensory changes, swelling, temperature or colour differences and movement abnormalities, then considers other explanations such as arthritis, infection, thrombosis or nerve damage. The commonly used Budapest criteria help standardise that assessment.

There is no routine genetic test that confirms RSD or CRPS, and no single genetic profile has been approved for diagnosis. MRI, ultrasound and nerve testing may be used to rule out other conditions or clarify nerve injury. In a family with several affected relatives, a neurologist or clinical geneticist can discuss whether formal testing has any useful purpose.

When several possible explanations compete, clinicians prioritise investigations and referrals in much the same way software orders tasks. This explanation of priority queue applications makes the difference between urgency and importance easy to see. Genetic results, if relevant, must still be interpreted alongside symptoms and examination findings.

Treatment and rehabilitation

Management is individualised and usually multidisciplinary. Early care can reduce disability, while longer-standing CRPS often needs coordinated pain, movement and psychological support.

Treatment may include:

  • Education about CRPS, pacing and a written recovery plan
  • Physiotherapy and occupational therapy using gradual, tolerable movement
  • Medicines for neuropathic pain, with options and PBS eligibility reviewed by the prescriber
  • Selected procedures such as nerve blocks and specialist options for refractory pain
  • Sleep treatment, graded activity and psychological care for coping and function

Rehabilitation aims to restore function rather than eliminate every painful sensation. Pacing, rest and carefully adjusted activity can reduce flares and prevent a cycle of overdoing tasks followed by prolonged recovery.

Rehabilitation strategies may include:

  • Gentle range-of-motion work and gradual strengthening as tolerated
  • Desensitisation of sensitive skin and careful handling education
  • Mirror therapy or other strategies used by a qualified clinician
  • Practical aids, workplace adjustments and home modifications
  • Support for sleep, fatigue and mood symptoms

Living with chronic regional pain can bring grief, fear, anger, low mood and social isolation, especially when appearance or mobility change. Psychological therapy can help with coping and does not mean the pain is psychological. A useful everyday metaphor comes from this arts piece on finding visual breathing room: a crowded schedule benefits from deliberate pauses, just as rehabilitation benefits from planned activity and rest.

Support and care pathways in Australia

In Australia, a GP is the usual entry point for Medicare-subsidised assessment and referral. Consultations listed on the Medicare Benefits Schedule may attract a rebate, while public hospital pain services and private multidisciplinary clinics in Melbourne, Sydney, Brisbane, Perth and Adelaide offer different pathways. Waiting times, eligibility and out-of-pocket costs vary, so the local service should be checked before booking.

The Pharmaceutical Benefits Scheme can subsidise eligible medicines, although coverage and prescribing criteria change, and not every treatment used for CRPS is PBS-listed. The National Disability Insurance Scheme may assist eligible people with disability-related supports, although CRPS alone does not determine eligibility. Treatment connected with a work injury or motor vehicle accident may instead run through workers’ compensation or state-based schemes such as TAC in Victoria and icare in NSW.

Regional and remote Australians may use telehealth and local GP services to reduce travel, while people in cities may still face crowded clinics and several separate waiting lists. If CRPS is suspected, begin with a GP appointment, request a pain clinic or neurology referral, and bring a symptom timeline, medication list and notes on relatives with similar symptoms. Starting that coordinated pathway early gives the care team the clearest picture of symptoms, function and family history.